Impact of Extrarenal Myoglobin Clearance on Renal Recovery in Patients With Severe Rhabdomyolysis (MYORHEIN)
Retrospective Evaluation of the Impact of Extrarenal Myoglobin Clearance on Renal Recovery in Patients With Severe Rhabdomyolysis
Severe rhabdomyolysis is a common medical emergency that can lead to acute kidney injury (AKI), sometimes requiring extracorporeal renal replacement therapy (ECRT). Myoglobin plays a major role among the molecules involved in nephrotoxicity. While ECRT techniques are commonly used in this situation, their actual effectiveness in eliminating myoglobin and improving renal function remains poorly established. In particular, mid-cut-off membranes, developed to better remove intermediate molecular weight molecules, could improve renal prognosis. This study aims to evaluate, using retrospective clinical data, the impact of these techniques on renal recovery.
研究概览
地位
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Nans FLORENS, MD
- 电话号码:33 3 69 55 13 25
- 邮箱:nans.florens@chru-strasbourg.fr
学习地点
-
-
-
Strasbourg、法国、67091
- 招聘中
- Service de Néphrologie Dialyse Transplantation - CHU de Strasbourg - France
-
接触:
- Nans FLORENS, MD
- 电话号码:33 3 69 55 13 25
- 邮箱:nans.florens@chru-strasbourg.fr
-
首席研究员:
- Nans FLORENS, MD
-
副研究员:
- Candice BARRIERE, MD
-
副研究员:
- Maxime INGWILLER, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Adult patient (≥18 years) with confirmed diagnosis of severe rhabdomyolysis associated with acute kidney injury, with or without renal replacement therapy.
描述
Inclusion Criteria:
- Adult patient (≥18 years).
- Patient is hospitalized in the nephrology or medical intensive care units of the Strasbourg University Hospitals (NHC or Hautepierre) between 2015 and 2024.
- Confirmed diagnosis of severe rhabdomyolysis associated with acute kidney injury, with or without renal replacement therapy.
- Patient has not objected to the reuse of their medical data.
Exclusion criteria:
- Patient has objected to the reuse of their data.
- Incomplete medical file preventing the complete analysis of the data necessary for the study.
- Subject under guardianship, curatorship, or legal protection.
学习计划
研究是如何设计的?
设计细节
- 观测模型:CASE_ONLY
- 时间观点:RETROSPECTIVE
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Total duration of dependence on extrarenal purification (ERP) (in days)
大体时间:up to 15 month
|
Total duration of dependence on ERC (in days), defined as the number of days between initiation and discontinuation of any form of dialysis. |
up to 15 month
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 9619
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.